These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26705859)

  • 21. N-Acetyl-D-glucosamine decorated polymeric nanoparticles for targeted delivery of doxorubicin: Synthesis, characterization and in vitro evaluation.
    Tian B; Ding Y; Han J; Zhang J; Han Y; Han J
    Colloids Surf B Biointerfaces; 2015 Jun; 130():246-54. PubMed ID: 25921641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naturally Derived Iron Oxide Nanowires from Bacteria for Magnetically Triggered Drug Release and Cancer Hyperthermia in 2D and 3D Culture Environments: Bacteria Biofilm to Potent Cancer Therapeutic.
    Kumeria T; Maher S; Wang Y; Kaur G; Wang L; Erkelens M; Forward P; Lambert MF; Evdokiou A; Losic D
    Biomacromolecules; 2016 Aug; 17(8):2726-36. PubMed ID: 27428076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic field triggered drug release from polymersomes for cancer therapeutics.
    Oliveira H; Pérez-Andrés E; Thevenot J; Sandre O; Berra E; Lecommandoux S
    J Control Release; 2013 Aug; 169(3):165-70. PubMed ID: 23353805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Water dispersible Fe3O4 nanoparticles carrying doxorubicin for cancer therapy.
    Jayakumar OD; Ganguly R; Tyagi AK; Chandrasekharan DK; Nair CK
    J Nanosci Nanotechnol; 2009 Nov; 9(11):6344-8. PubMed ID: 19908532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
    Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
    Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems.
    Lee SF; Zhu XM; Wang YX; Xuan SH; You Q; Chan WH; Wong CH; Wang F; Yu JC; Cheng CH; Leung KC
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1566-74. PubMed ID: 23402574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
    Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smart and dual-targeted BSA nanomedicine with controllable release by high autolysosome levels.
    Zhang Z; Dong C; Yu G; Cheng W; Liang Y; Pan Y; Li H; Ji H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110325. PubMed ID: 31301582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetocaloric effect in magnetothermally-responsive nanocarriers for hyperthermia-triggered drug release.
    Li J; Qu Y; Ren J; Yuan W; Shi D
    Nanotechnology; 2012 Dec; 23(50):505706. PubMed ID: 23183247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled co-release of doxorubicin and reactive oxygen species for synergistic therapy by NIR remote-triggered nanoimpellers.
    Hou B; Yang W; Dong C; Zheng B; Zhang Y; Wu J; Wang H; Chang J
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():94-102. PubMed ID: 28254338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polytyrosine nanoparticles enable ultra-high loading of doxorubicin and rapid enzyme-responsive drug release.
    Gu X; Qiu M; Sun H; Zhang J; Cheng L; Deng C; Zhong Z
    Biomater Sci; 2018 May; 6(6):1526-1534. PubMed ID: 29666858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
    Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
    Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of magnetic molecularly imprinted polymer nanoparticles for controlled release of doxorubicin under an alternative magnetic field in athermal conditions.
    Griffete N; Fresnais J; Espinosa A; Wilhelm C; Bée A; Ménager C
    Nanoscale; 2015 Dec; 7(45):18891-6. PubMed ID: 26515533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy.
    Zhao X; Jia X; Liu L; Zeng J; Tian K; Zhou T; Liu P
    Biomacromolecules; 2016 Apr; 17(4):1496-505. PubMed ID: 27010934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.